SAPS-010 - Trends in syphilis treatments and the impact of intramuscular injectable benzathine penicillin G in Japan: A descriptive study from April 2016 to September 2023

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: SAPS-010
• By: SHOJI, Tomokazu (Department of Pharmacy, University Of Yamanashi Hospital, Japan)
• Co-author(s): PhD Tomokazu Shoji (Department of Pharmacy, University Of Yamanashi Hospital, Chuo, Japan / Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Kiyose, Japan)
  Prof. Manabu Akazawa (Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Kiyose, Japan)
  Prof. Osamu Inoue (Division of Infection Control and Prevention, University of Yamanashi Hospital, Chuo, Japan)
  Prof. Takaaki Suzuki (Department of Pharmacy, University Of Yamanashi Hospital, Chuo, Japan)
  
• Abstract:

  Background
  Syphilis is a sexually transmitted disease caused by Treponema pallidum. The incidence of syphilis in Japan has been increasing in recent years, it becomes a significant public health threat. A new treatment for syphilis, involving intramuscular penicillin injections that require only a few doses, was launched in January 2022 in Japan...

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login